EXPONENT, INC. vs Genpact Limited, two Consulting stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where EXPO and G diverge most: on debt / equity, EXPO reads 0.00 and G reads 0.45; on p/b, EXPO reads 11.84 and G reads 2.25. The rest of the comparable metrics sit closer together. What EXPO's price implies is a bet that sits within the historical range (whole-company basis). What G's price implies is a bet that sits within the historical range (whole-company basis). The bull and bear cases for each are in their full reports below.
| Metric | EXPO | G |
|---|---|---|
| Price | $69.77 | $34.41 |
| Market cap | $3.4B | $5.9B |
| Sector | Consulting | Consulting |
| Stage | Mature | Mature |
| Implied growth (priced in) | +22.1% | — |
| P/E | 31.4 | 10.2 |
| P/B | 11.84 | 2.25 |
| P/S | 5.40 | 1.12 |
| EV/EBITDA | 24.3 | 8.0 |
| Revenue growth | +12.7% | +6.5% |
| Gross margin | — | 36.5% |
| Operating margin | 16.3% | 14.4% |
| Net margin | 17.7% | 11.1% |
| Return on equity | 38.7% | 22.4% |
| Return on assets | 17.1% | 10.8% |
| Return on invested capital | 31.9% | 15.7% |
| FCF yield | 3.2% | 9.8% |
| Dividend yield | 1.7% | 2.0% |
| Debt / equity | 0.00 | 0.45 |
| Current ratio | 1.98 | 2.00 |
| Altman Z (solvency) | 8.52 | 2.97 |
| Piotroski F (quality) | 8 / 9 | 6 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.